- Have any questions?
- +(86) 17612182560
- liusir@boomschem.com
Degarelix is a gonadotropin-releasing hormone (GnRH) antagonist that is used in the treatment of prostate cancer
| CAS | 214766-78-6 |
|---|---|
| Sequence | Ac-D2Nal-D4Cpa-3Pal-Ser-4Aph(Hor)-D4Aph(Cbm)-Leu-Lys(Ipr)-Pro-DAla-NH2 |
| Molecular Formula | C82H103ClN18O16 |
| Molar Mass | 1630.75 g/mol |
| Purity | ≥98% |
| Storage Conditions | 2-8℃ |
| Packing Specifications | 100mg、1g、10g、100g or at customers request |
Prostate Cancer: Degarelix is used for the treatment of patients with advanced prostate cancer. It is often used as a first-line therapy for men with hormone-sensitive prostate cancer. It works by rapidly reducing the levels of testosterone in the body, which helps to slow down the growth of prostate cancer cells.
The product is only for research and development and export to legal areas, personal use is prohibited
PS: All adverse consequences are at your own risk
